Nath Bio-Genes (India) Ltd

NSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Nath Bio-Genes (India) Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
32.23% Gain from 52W Low
-4.8
TTM PE Ratio
Below industry Median
9.6
Price to Book Ratio
Low in industry
0.7
Dividend yield 1yr %
Above industry Median
1
TTM PEG Ratio
PEG TTM is less than 1
0.1
RSI
RSI is mid-range
64.7
MFI
MFI is mid-range
66.9

Nath Bio-Genes (India) Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Nath Bio-Genes (India) Ltd shareholding Pattern

Promoter
45.6%
Foreign Institutions
0.3%
Mutual Funds
4.4%
Domestic Institutions
4.4%
Public
49.8%
Promoter
45.6%
Foreign Institutions
0.3%
Mutual Funds
4.4%
Domestic Institutions
4.4%
Public
49.7%
Promoter
45.6%
Foreign Institutions
0.2%
Mutual Funds
4.4%
Domestic Institutions
4.4%
Public
49.8%
Promoter
45.6%
Foreign Institutions
0.1%
Mutual Funds
4.6%
Domestic Institutions
4.6%
Public
49.7%
Promoter
45.6%
Foreign Institutions
0.1%
Mutual Funds
4.6%
Domestic Institutions
4.6%
Public
49.6%
Promoter
45.6%
Foreign Institutions
0.2%
Mutual Funds
4.6%
Domestic Institutions
4.6%
Public
49.6%

Nath Bio-Genes (India) Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
201.20
10Day EMA
197.60
12Day EMA
196.60
20Day EMA
194.40
26Day EMA
194.10
50Day EMA
196.00
100Day EMA
199.20
200Day EMA
198.60
5Day SMA
201.60
10Day SMA
196.00
20Day SMA
191.60
30Day SMA
188.40
50Day SMA
196.00
100Day SMA
203.10
150Day SMA
202.30
200Day SMA
205.90
Delivery & Volume
Resistance & Support
205.20
Pivot
Resistance
First Resistance
211.35
Second Resistance
215.30
Third Resistance
221.45
Support
First Support
201.25
Second support
195.10
Third Support
191.15
Relative Strength Index
64.68
Money Flow Index
66.92
MACD
2.54
MACD Signal
0.30
Average True Range
7.80
Average Directional Index
18.31
Rate of Change (21)
13.52
Rate of Change (125)
13.30
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Sukhjit Starch & Chemicals Ltd.
-
-
-
Mangalam Seeds Ltd.
-
-
-
Prime Fresh Ltd.
-
-
-
Indo US Bio-Tech Ltd.
-
-
-
Mangalam Global Enterprise Ltd.
335.22
12.65
28.2
Tierra Agrotech Ltd.
-
-
-

Nath Bio-Genes (India) Ltd Company background

Founded in: 1993
Managing director: Satish Kagliwal
Nath BioGenes (India) Limited was incorporated as Shivnath Farms Private Limited on July 14, 1993 as a private limited company under the Companies Act, 1956. The company is engaged in the business of production, processing, and marketing of hybrid and GM seeds. The Company has a product range of field crops, vegetable crops and plant nutrient supplements. The major processing plants are situated at Aurangabad (MS), and Munipalli, Nizamabad (TG). The company has a pan India presence for sales through an extensive network of distributors.In India, the company has nearly 16 business centres covering 131 territories connecting with over 2,000 distributors, all across the country. The company has been presently venturing to newer geographies outside the country, possessing similar agronomical conditions as India. all set to spread its wings in other parts of Asia, Africa the Middle East. The company has developed modern infrastructure facilities, biotech lab and seed technology lab. It has a wide dealers and distribution network of PAN India marketing distribution network which is manned by technically and commercially skilled marketing team. The Company produced several highly ranked cotton seeds in the country which have done well in the ICAR trials and stood the test of time with respect to various virus tolerance as well as improved yield in spite of weather fluctuations. It is the first seed company in Asia Pacific region to get ISO 9001 certificate. Its new launches Sanket and Daksh cotton seeds have been ranked among top 3 in most geographies and under various planting conditions. The consistent high rank achieved by companys new seeds gives reasonable confidence about it growing its cotton seeds portfolio faster than the industry. The strategy is to provide farmers with a wide range of varieties of cotton seeds suitable for diverse climatic conditions while maintaining yield superiority. The company has worked on derisking its business by having multiple growth drivers like paddy, vegetable seeds and plant nutrient in its portfolio. The company established a network of over 15,000 farmers growing seeds. It has been awarded with the prestigious Vasantrao Naik Prathisthan Award for its contribution for enhancing Agricultural Productivity amongst other rewards recognition.At present, the company has about 18 breeding and evaluation RD Stations in different agroclimatic conditions. It has more than 300 acres of land dedicated to research and development, across the nation. It has collaboration with reputed International and National Centres of Excellence (NRCPB, CIMMYT, IRRI, ICRISAT Etc.) The company has a team of handpicked plant breeders and bio technologists, located at key RD stations, across the country, guided by RD veterans. It undertakes seed production in over 30,000 acres of land with about 25,000 loyal growers and 72 technically qualified organizers. The company assures that seeds of the highest quality reaches the processing centers by setting rigorous field standards and quality control checks throughout the seed production process. The company has elaborate seed processing facilities with 10 Processing Plants located in Maharashtra and Andhra Pradesh. It has processing arrangements in Gujarat, Karnataka, Tamil Nadu, Madhya Pradesh and Rajasthan on custom basis. The seeds receivedfrom growers are processed to achieve quality standards which surpass those prescribed by the regulatory authorities. All the plants areequipped with precleaner, fine cleaner, grader, gravity separator, destoner, indented cylinder, treater, needle separator and packingmachines which are fully automated. The company has independent facilities for ginning, delinting, drying, processing, treating, packingand storage of seeds. The seed processing quality is taken to the next level by ensuring improvements in seed viability and prolonging theshelf life of seeds. All the packing material has best environmental barriers characteristics to guarantee optimal storage conditions for the seed.The companys key function is to rigorously test products in various agroclimatic regions and compare the yield to benchmark products of competitors. The product undergoes a rigorous state gate screening process comprising six stages prior to commercial release. Seed Production and Disease Screening are an instrumental part of product development with testing spread across 40 locations, 8 centres and all agroclimatic zones of India. Besides, trials are conducted in three phases to thoroughly test the performance of products before recommending for a national launch. The three different phases of trials are MLT (Multi Location Trial), LST (Large scale Trial) and Demonstrations. For the Multilevel trials, the company have nearly eight stations each at a different agroclimatic zone divided across the length and breadth of the country.
Read More

Nath Bio-Genes (India) Ltd FAQs

Nath Bio-Genes (India) Ltd shares are currently priced at 207.4 on NSE and 207.2 on BSE as of 4/25/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Nath Bio-Genes (India) Ltd [NATHBIOGEN] share was 30.15. The Nath Bio-Genes (India) Ltd [NATHBIOGEN] share hit a 1-year low of Rs. 159 and a 1-year high of Rs. 244.6.

The market cap of Nath Bio-Genes (India) Ltd is Rs. 394.14 Cr. as of 4/25/2024 12:00:00 AM.

The PE ratios of Nath Bio-Genes (India) Ltd is 10.35 as of 4/25/2024 12:00:00 AM.

The PB ratios of Nath Bio-Genes (India) Ltd is 0.65 as of 4/25/2024 12:00:00 AM

The Mutual Fund Shareholding was 4.37% at the end of 4/25/2024 12:00:00 AM.

You can easily buy Nath Bio-Genes (India) Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage